NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients

被引：4
|
作者：
Doss, Sally [1 ]
Garrett, Zoe [1 ]
Sutcliffe, Frances [1 ]
Stevens, Andrew [1 ]
机构：
[1] Natl Inst Hlth & Clin Excellence, Manchester, Lancs, England
来源：
LANCET ONCOLOGY | 2012年 / 13卷 / 02期
关键词：
CHEMOTHERAPY; CYCLOPHOSPHAMIDE; CHLORAMBUCIL; VINCRISTINE; COMBINATION; INTERFERON; PREDNISONE; CVP;
D O I：
10.1016/S1470-2045(12)70009-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：128 / 130
页数：4
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY OF RITUXIMAB AND CHLORAMBUCIL IN COMBINATION AS FIRST-LINE TREATMENT IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS
    Martinelli, G.
    Andreola, G.
    Laszlo, D.
    Minga, P.
    Cannella, L.
    Liptrott, S.
    Sammassimo, S.
    Linetti, M.
    Calabrese, L.
    Bassi, S.
    [J]. HAEMATOLOGICA, 2012, 97 : 651 - 652
  • [2] Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
    Dundar, Y.
    Bagust, A.
    Hounsome, J.
    McLeod, C.
    Boland, A.
    Davis, H.
    Walley, T.
    Dickson, R.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 23 - 28
  • [3] Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation
    Papaioannou, D.
    Rafia, R.
    Rathbone, J.
    Stevenson, M.
    Woods, H. Buckley
    Stevens, J.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (37) : 1 - +
  • [4] Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Schiattone, Luana
    Bartalucci, Giulia
    Bocchia, Monica
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (10) : 2997 - 2998
  • [5] 2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma
    Betticher, DC
    Zucca, E
    vonRohr, A
    Egger, T
    Radford, JA
    Ambrosetti, A
    Burki, K
    Rufener, B
    Schmitz, SFH
    Cerny, T
    [J]. ANNALS OF ONCOLOGY, 1996, 7 (08) : 793 - 799
  • [6] Fludarabine, cyclophosphamide and rituximab as first-line treatment in patients with newly diagnosed follicular lymphoma
    De la Cruz Vicente, Fatima
    Carrillo-Cruz, Estrella
    Sole Rodriguez, Maria
    Marin Niebla, Ana
    Martino Galiana, Maria Luz
    Falantes Gonzalez, Jose
    Montero Cuadrado, Isabel
    Gonzalez Campos, Jose
    Espigado Tocino, Ildefonso
    Rios-Herranz, Eduardo
    Antonio Perez-Simon, Jose
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (06) : 469 - 475
  • [7] Rituximab for the First-Line Maintenance Treatment of Follicular Non-Hodgkin's Lymphoma A NICE Single Technology Appraisal
    Greenhalgh, Janette
    Bagust, Adrian
    Boland, Angela
    Blundell, Michaela
    Oyee, James
    Beale, Sophie
    Dundar, Yenal
    Hockenhull, Juliet
    Proudlove, Chris
    Chu, Patrick
    [J]. PHARMACOECONOMICS, 2013, 31 (05) : 403 - 413
  • [8] SINGLE AGENT RITUXIMAB IS A VALID OPTION FOR FIRST-LINE TREATMENT IN FOLLICULAR LYMPHOMA
    Ghielmini, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 81 - 81
  • [9] FIRST LINE TREATMENT WITH BENDAMUSTINE-RITUXIMAB IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Buenasmananas Cervantes, D.
    Calle Primo, C.
    Nebro Luque, M. dM
    Hernandez Ruiz, B.
    [J]. HAEMATOLOGICA, 2015, 100 : 266 - 266
  • [10] Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma
    Reagan, Patrick M.
    Friedberg, Jonathan W.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (07)
12345